This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

7 Dec 2010

U.S. Food and Drug Administration Accepts Supplemental Biologics License Application

Bristol-Myers Squibb Company announced that FDA has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA? (abatacept)

Related News